Symposia: Aggressive Lymphomas: Pharmacologic Therapies
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Adult, Combination therapy, Lymphomas, Bispecific Antibody Therapy, Non-Hodgkin lymphoma, Clinical Research, B Cell lymphoma, Diseases, Real-world evidence, Treatment Considerations, Biological therapies, Immunotherapy, Aggressive lymphoma, Lymphoid Malignancies, Technology and Procedures, Study Population, Human, Profiling
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Adult, Combination therapy, Lymphomas, Bispecific Antibody Therapy, Non-Hodgkin lymphoma, Clinical Research, B Cell lymphoma, Diseases, Real-world evidence, Treatment Considerations, Biological therapies, Immunotherapy, Aggressive lymphoma, Lymphoid Malignancies, Technology and Procedures, Study Population, Human, Profiling
Monday, December 9, 2024: 2:45 PM-4:15 PM
Pacific Ballroom Salons 15-17
(Marriott Marquis San Diego Marina)
Moderators:
Muhit Ozcan, MD,
and
Christopher Melani, MD, National Cancer Institute, National Institutes of Health
Disclosures:
No relevant conflicts of interest to declare.
This session focuses on novel monotherapies and some novel combinations in rare diseases for aggressive lymphomas.
2:45 PM
3:00 PM
3:15 PM
3:30 PM
3:45 PM
4:00 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH